Mexoryl SX (Ecamsule) Market By Purity Level (Less than 98%, More than 98%), By Application (Cosmetics, Pharmaceuticals, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global mexoryl SX (ecamsule) market was valued at $49.5 million in 2021, and is projected to reach $82.6 million by 2031, growing at a CAGR of 5.3% from 2022 to 2031.
Mexoryl SX is the trade name for ecamsule, or terephthalylidene dicamphor sulfonic acid. It is an organic sun filter (carbon-based) developed and patented by L'Oréal in 1982. It protects mainly against UVA rays, the main cause of premature skin aging and skin cancers. In addition, it is used as a photostable drug that resists the formation of UV induced pyrimidine dimers and delays the onset of skin cancer.
The increasing awareness toward skincare, beauty, and lifestyle has surged the demand for personal care & cosmetic products where mexoryl SX (ecamsule) protects skin mainly from long wave ultraviolet A (UVA) rays that is the main cause of premature skin aging and skin cancers. This may propel the growth of the mexoryl SX) ecamsule) market. In addition, rise in concerns about skin protection against detrimental rays of the sun and improved alertness regarding skin cancer have led the customers become more linear toward using mexoryl SX (ecamsule)-based sunscreens, which fosters the growth of the mexoryl SX (ecamsule) market.
However, mexoryl SX (ecamsule) is a newly developed product and is relatively new in the market. It requires certain testing and approvals for its adoption among various end use applications. For instance, food and drug administration (FDA) is proposing to prevent the use of ecamsule and anzacamene in sunscreens due to their ineffectiveness. Thus, FDA’s action means that Americans may not have access to these products. This factor may hamper the growth of the mexoryl SX (ecamsule) market during the forecast period.
On the contrary, surge in R&D activities for developing a broad spectrum of sunscreens formulation where mexoryl SX (ecamsule) is widely used for photo-protection purposes in all skin types may create new opportunities for the market.
The mexoryl SX (ecamsule) market is segmented into purity level, application, and region. On the basis of purity level, the market is segregated into less than 98% and more than 98%. Depending on application, it is fragmented into cosmetics, phamraceuticals, and others. Region wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.
The leading players operating in the global mexoryl SX (ecamsule) market include Biosynth Carbosynth, ChemScene LLC, Derma Company, National Analytical Corporation, Norna Technology Co., Skylead Pharmaceuticals & Chemicals, L'Oréal S.A., and MFCI CO.,LTD (Hubei Meifeng Chemical Co., Ltd.). The global mexoryl SX (ecamsule) market report provides in-depth competitive analysis as well as profiles of these major players.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the mexoryl sx (ecamsule) market analysis from 2021 to 2031 to identify the prevailing mexoryl sx (ecamsule) market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the mexoryl sx (ecamsule) market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global mexoryl sx (ecamsule) market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Purity Level
Less than 98%
More than 98%
By Application
Cosmetics
Pharmaceuticals
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific
Australia
Rest of Asia-Pacific
China
India
Japan
South Korea
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
L'Oréal S.A.
Skylead Pharmaceuticals & Chemicals
ChemScene LLC
Biosynth Carbosynth
NATIONAL ANALYTICAL CORPORATION
Norna Technology Co.
Derma Companies
MFCI CO.,LTD
Merck KGaA
Parchem Fine and Specialty Chemicals
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- 3.7.Pricing Analysis
- 3.8.Value Chain Analysis
- 3.9.Key Regulation Analysis
- 3.10.Patent Landscape
- CHAPTER 4: MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Less than 98%
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 More than 98%
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- CHAPTER 5: MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Cosmetics
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Pharmaceuticals
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Others
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- CHAPTER 6: MEXORYL SX (ECAMSULE) MARKET, BY REGION
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 North America
- 6.2.1 Key trends and opportunities
- 6.2.2 North America Market size and forecast, by Purity Level
- 6.2.3 North America Market size and forecast, by Application
- 6.2.4 North America Market size and forecast, by country
- 6.2.4.1 U.S.
- 6.2.4.1.1 Market size and forecast, by Purity Level
- 6.2.4.1.2 Market size and forecast, by Application
- 6.2.4.2 Canada
- 6.2.4.2.1 Market size and forecast, by Purity Level
- 6.2.4.2.2 Market size and forecast, by Application
- 6.2.4.3 Mexico
- 6.2.4.3.1 Market size and forecast, by Purity Level
- 6.2.4.3.2 Market size and forecast, by Application
- 6.3 Europe
- 6.3.1 Key trends and opportunities
- 6.3.2 Europe Market size and forecast, by Purity Level
- 6.3.3 Europe Market size and forecast, by Application
- 6.3.4 Europe Market size and forecast, by country
- 6.3.4.1 Germany
- 6.3.4.1.1 Market size and forecast, by Purity Level
- 6.3.4.1.2 Market size and forecast, by Application
- 6.3.4.2 United Kingdom
- 6.3.4.2.1 Market size and forecast, by Purity Level
- 6.3.4.2.2 Market size and forecast, by Application
- 6.3.4.3 France
- 6.3.4.3.1 Market size and forecast, by Purity Level
- 6.3.4.3.2 Market size and forecast, by Application
- 6.3.4.4 Spain
- 6.3.4.4.1 Market size and forecast, by Purity Level
- 6.3.4.4.2 Market size and forecast, by Application
- 6.3.4.5 Italy
- 6.3.4.5.1 Market size and forecast, by Purity Level
- 6.3.4.5.2 Market size and forecast, by Application
- 6.3.4.6 Rest of Europe
- 6.3.4.6.1 Market size and forecast, by Purity Level
- 6.3.4.6.2 Market size and forecast, by Application
- 6.4 Asia-Pacific
- 6.4.1 Key trends and opportunities
- 6.4.2 Asia-Pacific Market size and forecast, by Purity Level
- 6.4.3 Asia-Pacific Market size and forecast, by Application
- 6.4.4 Asia-Pacific Market size and forecast, by country
- 6.4.4.1 China
- 6.4.4.1.1 Market size and forecast, by Purity Level
- 6.4.4.1.2 Market size and forecast, by Application
- 6.4.4.2 India
- 6.4.4.2.1 Market size and forecast, by Purity Level
- 6.4.4.2.2 Market size and forecast, by Application
- 6.4.4.3 Japan
- 6.4.4.3.1 Market size and forecast, by Purity Level
- 6.4.4.3.2 Market size and forecast, by Application
- 6.4.4.4 South Korea
- 6.4.4.4.1 Market size and forecast, by Purity Level
- 6.4.4.4.2 Market size and forecast, by Application
- 6.4.4.5 Australia
- 6.4.4.5.1 Market size and forecast, by Purity Level
- 6.4.4.5.2 Market size and forecast, by Application
- 6.4.4.6 Rest of Asia-Pacific
- 6.4.4.6.1 Market size and forecast, by Purity Level
- 6.4.4.6.2 Market size and forecast, by Application
- 6.5 LAMEA
- 6.5.1 Key trends and opportunities
- 6.5.2 LAMEA Market size and forecast, by Purity Level
- 6.5.3 LAMEA Market size and forecast, by Application
- 6.5.4 LAMEA Market size and forecast, by country
- 6.5.4.1 Brazil
- 6.5.4.1.1 Market size and forecast, by Purity Level
- 6.5.4.1.2 Market size and forecast, by Application
- 6.5.4.2 Saudi Arabia
- 6.5.4.2.1 Market size and forecast, by Purity Level
- 6.5.4.2.2 Market size and forecast, by Application
- 6.5.4.3 South Africa
- 6.5.4.3.1 Market size and forecast, by Purity Level
- 6.5.4.3.2 Market size and forecast, by Application
- 6.5.4.4 Rest of LAMEA
- 6.5.4.4.1 Market size and forecast, by Purity Level
- 6.5.4.4.2 Market size and forecast, by Application
- CHAPTER 7: COMPANY LANDSCAPE
- 7.1. Introduction
- 7.2. Top winning strategies
- 7.3. Product Mapping of Top 10 Player
- 7.4. Competitive Dashboard
- 7.5. Competitive Heatmap
- 7.6. Key developments
- CHAPTER 8: COMPANY PROFILES
- 8.1 L'Oréal S.A.
- 8.1.1 Company overview
- 8.1.2 Company snapshot
- 8.1.3 Operating business segments
- 8.1.4 Product portfolio
- 8.1.5 Business performance
- 8.1.6 Key strategic moves and developments
- 8.2 Skylead Pharmaceuticals & Chemicals
- 8.2.1 Company overview
- 8.2.2 Company snapshot
- 8.2.3 Operating business segments
- 8.2.4 Product portfolio
- 8.2.5 Business performance
- 8.2.6 Key strategic moves and developments
- 8.3 ChemScene LLC
- 8.3.1 Company overview
- 8.3.2 Company snapshot
- 8.3.3 Operating business segments
- 8.3.4 Product portfolio
- 8.3.5 Business performance
- 8.3.6 Key strategic moves and developments
- 8.4 Biosynth Carbosynth
- 8.4.1 Company overview
- 8.4.2 Company snapshot
- 8.4.3 Operating business segments
- 8.4.4 Product portfolio
- 8.4.5 Business performance
- 8.4.6 Key strategic moves and developments
- 8.5 NATIONAL ANALYTICAL CORPORATION
- 8.5.1 Company overview
- 8.5.2 Company snapshot
- 8.5.3 Operating business segments
- 8.5.4 Product portfolio
- 8.5.5 Business performance
- 8.5.6 Key strategic moves and developments
- 8.6 Norna Technology Co.
- 8.6.1 Company overview
- 8.6.2 Company snapshot
- 8.6.3 Operating business segments
- 8.6.4 Product portfolio
- 8.6.5 Business performance
- 8.6.6 Key strategic moves and developments
- 8.7 Derma Companies
- 8.7.1 Company overview
- 8.7.2 Company snapshot
- 8.7.3 Operating business segments
- 8.7.4 Product portfolio
- 8.7.5 Business performance
- 8.7.6 Key strategic moves and developments
- 8.8 MFCI CO.,LTD
- 8.8.1 Company overview
- 8.8.2 Company snapshot
- 8.8.3 Operating business segments
- 8.8.4 Product portfolio
- 8.8.5 Business performance
- 8.8.6 Key strategic moves and developments
- 8.9 Merck KGaA
- 8.9.1 Company overview
- 8.9.2 Company snapshot
- 8.9.3 Operating business segments
- 8.9.4 Product portfolio
- 8.9.5 Business performance
- 8.9.6 Key strategic moves and developments
- 8.10 Parchem Fine and Specialty Chemicals
- 8.10.1 Company overview
- 8.10.2 Company snapshot
- 8.10.3 Operating business segments
- 8.10.4 Product portfolio
- 8.10.5 Business performance
- 8.10.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
- TABLE 2. GLOBAL MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
- TABLE 3. MEXORYL SX (ECAMSULE) MARKET SIZE, FOR LESS THAN 98%, BY REGION, 2021-2031 ($MILLION)
- TABLE 4. MEXORYL SX (ECAMSULE) MARKET SIZE, FOR LESS THAN 98%, BY REGION, 2021-2031 (TONS)
- TABLE 5. MEXORYL SX (ECAMSULE) MARKET FOR LESS THAN 98%, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 6. MEXORYL SX (ECAMSULE) MARKET FOR LESS THAN 98%, BY COUNTRY, 2021-2031 (TONS)
- TABLE 7. MEXORYL SX (ECAMSULE) MARKET SIZE, FOR MORE THAN 98%, BY REGION, 2021-2031 ($MILLION)
- TABLE 8. MEXORYL SX (ECAMSULE) MARKET SIZE, FOR MORE THAN 98%, BY REGION, 2021-2031 (TONS)
- TABLE 9. MEXORYL SX (ECAMSULE) MARKET FOR MORE THAN 98%, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 10. MEXORYL SX (ECAMSULE) MARKET FOR MORE THAN 98%, BY COUNTRY, 2021-2031 (TONS)
- TABLE 11. GLOBAL MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 12. GLOBAL MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
- TABLE 13. MEXORYL SX (ECAMSULE) MARKET SIZE, FOR COSMETICS, BY REGION, 2021-2031 ($MILLION)
- TABLE 14. MEXORYL SX (ECAMSULE) MARKET SIZE, FOR COSMETICS, BY REGION, 2021-2031 (TONS)
- TABLE 15. MEXORYL SX (ECAMSULE) MARKET FOR COSMETICS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 16. MEXORYL SX (ECAMSULE) MARKET FOR COSMETICS, BY COUNTRY, 2021-2031 (TONS)
- TABLE 17. MEXORYL SX (ECAMSULE) MARKET SIZE, FOR PHARMACEUTICALS, BY REGION, 2021-2031 ($MILLION)
- TABLE 18. MEXORYL SX (ECAMSULE) MARKET SIZE, FOR PHARMACEUTICALS, BY REGION, 2021-2031 (TONS)
- TABLE 19. MEXORYL SX (ECAMSULE) MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 20. MEXORYL SX (ECAMSULE) MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2021-2031 (TONS)
- TABLE 21. MEXORYL SX (ECAMSULE) MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 22. MEXORYL SX (ECAMSULE) MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 (TONS)
- TABLE 23. MEXORYL SX (ECAMSULE) MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 24. MEXORYL SX (ECAMSULE) MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (TONS)
- TABLE 25. MEXORYL SX (ECAMSULE) MARKET, BY REGION, 2021-2031 ($MILLION)
- TABLE 26. MEXORYL SX (ECAMSULE) MARKET, BY REGION, 2021-2031 (TONS)
- TABLE 27. NORTH AMERICA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
- TABLE 28. NORTH AMERICA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
- TABLE 29. NORTH AMERICA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 30. NORTH AMERICA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
- TABLE 31. NORTH AMERICA MEXORYL SX (ECAMSULE) MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 32. NORTH AMERICA MEXORYL SX (ECAMSULE) MARKET, BY COUNTRY, 2021-2031 (TONS)
- TABLE 33. U.S. MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
- TABLE 34. U.S. MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
- TABLE 35. U.S. MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 36. U.S. MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
- TABLE 37. CANADA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
- TABLE 38. CANADA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
- TABLE 39. CANADA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 40. CANADA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
- TABLE 41. MEXICO MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
- TABLE 42. MEXICO MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
- TABLE 43. MEXICO MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 44. MEXICO MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
- TABLE 45. EUROPE MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
- TABLE 46. EUROPE MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
- TABLE 47. EUROPE MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 48. EUROPE MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
- TABLE 49. EUROPE MEXORYL SX (ECAMSULE) MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 50. EUROPE MEXORYL SX (ECAMSULE) MARKET, BY COUNTRY, 2021-2031 (TONS)
- TABLE 51. GERMANY MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
- TABLE 52. GERMANY MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
- TABLE 53. GERMANY MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 54. GERMANY MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
- TABLE 55. UNITED KINGDOM MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
- TABLE 56. UNITED KINGDOM MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
- TABLE 57. UNITED KINGDOM MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 58. UNITED KINGDOM MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
- TABLE 59. FRANCE MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
- TABLE 60. FRANCE MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
- TABLE 61. FRANCE MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 62. FRANCE MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
- TABLE 63. SPAIN MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
- TABLE 64. SPAIN MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
- TABLE 65. SPAIN MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 66. SPAIN MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
- TABLE 67. ITALY MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
- TABLE 68. ITALY MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
- TABLE 69. ITALY MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 70. ITALY MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
- TABLE 71. REST OF EUROPE MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
- TABLE 72. REST OF EUROPE MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
- TABLE 73. REST OF EUROPE MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 74. REST OF EUROPE MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
- TABLE 75. ASIA-PACIFIC MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
- TABLE 76. ASIA-PACIFIC MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
- TABLE 77. ASIA-PACIFIC MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 78. ASIA-PACIFIC MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
- TABLE 79. ASIA-PACIFIC MEXORYL SX (ECAMSULE) MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 80. ASIA-PACIFIC MEXORYL SX (ECAMSULE) MARKET, BY COUNTRY, 2021-2031 (TONS)
- TABLE 81. CHINA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
- TABLE 82. CHINA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
- TABLE 83. CHINA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 84. CHINA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
- TABLE 85. INDIA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
- TABLE 86. INDIA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
- TABLE 87. INDIA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 88. INDIA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
- TABLE 89. JAPAN MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
- TABLE 90. JAPAN MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
- TABLE 91. JAPAN MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 92. JAPAN MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
- TABLE 93. SOUTH KOREA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
- TABLE 94. SOUTH KOREA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
- TABLE 95. SOUTH KOREA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 96. SOUTH KOREA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
- TABLE 97. AUSTRALIA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
- TABLE 98. AUSTRALIA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
- TABLE 99. AUSTRALIA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 100. AUSTRALIA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
- TABLE 101. REST OF ASIA-PACIFIC MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
- TABLE 102. REST OF ASIA-PACIFIC MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
- TABLE 103. REST OF ASIA-PACIFIC MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 104. REST OF ASIA-PACIFIC MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
- TABLE 105. LAMEA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
- TABLE 106. LAMEA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
- TABLE 107. LAMEA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 108. LAMEA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
- TABLE 109. LAMEA MEXORYL SX (ECAMSULE) MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 110. LAMEA MEXORYL SX (ECAMSULE) MARKET, BY COUNTRY, 2021-2031 (TONS)
- TABLE 111. BRAZIL MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
- TABLE 112. BRAZIL MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
- TABLE 113. BRAZIL MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 114. BRAZIL MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
- TABLE 115. SAUDI ARABIA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
- TABLE 116. SAUDI ARABIA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
- TABLE 117. SAUDI ARABIA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 118. SAUDI ARABIA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
- TABLE 119. SOUTH AFRICA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
- TABLE 120. SOUTH AFRICA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
- TABLE 121. SOUTH AFRICA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 122. SOUTH AFRICA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
- TABLE 123. REST OF LAMEA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 ($MILLION)
- TABLE 124. REST OF LAMEA MEXORYL SX (ECAMSULE) MARKET, BY PURITY LEVEL, 2021-2031 (TONS)
- TABLE 125. REST OF LAMEA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 126. REST OF LAMEA MEXORYL SX (ECAMSULE) MARKET, BY APPLICATION, 2021-2031 (TONS)
- TABLE 127.L'ORÉAL S.A.: COMPANY SNAPSHOT
- TABLE 128.L'ORÉAL S.A.: OPERATING SEGMENTS
- TABLE 129.L'ORÉAL S.A.: PRODUCT PORTFOLIO
- TABLE 130.L'ORÉAL S.A.: NET SALES,
- TABLE 131.L'ORÉAL S.A.: KEY STRATERGIES
- TABLE 132.SKYLEAD PHARMACEUTICALS & CHEMICALS: COMPANY SNAPSHOT
- TABLE 133.SKYLEAD PHARMACEUTICALS & CHEMICALS: OPERATING SEGMENTS
- TABLE 134.SKYLEAD PHARMACEUTICALS & CHEMICALS: PRODUCT PORTFOLIO
- TABLE 135.SKYLEAD PHARMACEUTICALS & CHEMICALS: NET SALES,
- TABLE 136.SKYLEAD PHARMACEUTICALS & CHEMICALS: KEY STRATERGIES
- TABLE 137.CHEMSCENE LLC: COMPANY SNAPSHOT
- TABLE 138.CHEMSCENE LLC: OPERATING SEGMENTS
- TABLE 139.CHEMSCENE LLC: PRODUCT PORTFOLIO
- TABLE 140.CHEMSCENE LLC: NET SALES,
- TABLE 141.CHEMSCENE LLC: KEY STRATERGIES
- TABLE 142.BIOSYNTH CARBOSYNTH: COMPANY SNAPSHOT
- TABLE 143.BIOSYNTH CARBOSYNTH: OPERATING SEGMENTS
- TABLE 144.BIOSYNTH CARBOSYNTH: PRODUCT PORTFOLIO
- TABLE 145.BIOSYNTH CARBOSYNTH: NET SALES,
- TABLE 146.BIOSYNTH CARBOSYNTH: KEY STRATERGIES
- TABLE 147.NATIONAL ANALYTICAL CORPORATION: COMPANY SNAPSHOT
- TABLE 148.NATIONAL ANALYTICAL CORPORATION: OPERATING SEGMENTS
- TABLE 149.NATIONAL ANALYTICAL CORPORATION: PRODUCT PORTFOLIO
- TABLE 150.NATIONAL ANALYTICAL CORPORATION: NET SALES,
- TABLE 151.NATIONAL ANALYTICAL CORPORATION: KEY STRATERGIES
- TABLE 152.NORNA TECHNOLOGY CO.: COMPANY SNAPSHOT
- TABLE 153.NORNA TECHNOLOGY CO.: OPERATING SEGMENTS
- TABLE 154.NORNA TECHNOLOGY CO.: PRODUCT PORTFOLIO
- TABLE 155.NORNA TECHNOLOGY CO.: NET SALES,
- TABLE 156.NORNA TECHNOLOGY CO.: KEY STRATERGIES
- TABLE 157.DERMA COMPANIES: COMPANY SNAPSHOT
- TABLE 158.DERMA COMPANIES: OPERATING SEGMENTS
- TABLE 159.DERMA COMPANIES: PRODUCT PORTFOLIO
- TABLE 160.DERMA COMPANIES: NET SALES,
- TABLE 161.DERMA COMPANIES: KEY STRATERGIES
- TABLE 162.MFCI CO.,LTD: COMPANY SNAPSHOT
- TABLE 163.MFCI CO.,LTD: OPERATING SEGMENTS
- TABLE 164.MFCI CO.,LTD: PRODUCT PORTFOLIO
- TABLE 165.MFCI CO.,LTD: NET SALES,
- TABLE 166.MFCI CO.,LTD: KEY STRATERGIES
- TABLE 167.MERCK KGAA: COMPANY SNAPSHOT
- TABLE 168.MERCK KGAA: OPERATING SEGMENTS
- TABLE 169.MERCK KGAA: PRODUCT PORTFOLIO
- TABLE 170.MERCK KGAA: NET SALES,
- TABLE 171.MERCK KGAA: KEY STRATERGIES
- TABLE 172.PARCHEM FINE AND SPECIALTY CHEMICALS: COMPANY SNAPSHOT
- TABLE 173.PARCHEM FINE AND SPECIALTY CHEMICALS: OPERATING SEGMENTS
- TABLE 174.PARCHEM FINE AND SPECIALTY CHEMICALS: PRODUCT PORTFOLIO
- TABLE 175.PARCHEM FINE AND SPECIALTY CHEMICALS: NET SALES,
- TABLE 176.PARCHEM FINE AND SPECIALTY CHEMICALS: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.MEXORYL SX (ECAMSULE) MARKET SEGMENTATION
- FIGURE 2.MEXORYL SX (ECAMSULE) MARKET,2021-2031
- FIGURE 3.MEXORYL SX (ECAMSULE) MARKET,2021-2031
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.MEXORYL SX (ECAMSULE) MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 12.PRICING ANALYSIS
- FIGURE 13.VALUE CHAIN ANALYSIS
- FIGURE 14.KEY REGULATION ANALYSIS
- FIGURE 15.PATENT ANALYSIS BY COMPANY
- FIGURE 16.PATENT ANALYSIS BY COUNTRY
- FIGURE 17.MEXORYL SX (ECAMSULE) MARKET,BY PURITY LEVEL,2021(%)
- FIGURE 18.COMPARATIVE SHARE ANALYSIS OF LESS THAN 98% MEXORYL SX (ECAMSULE) MARKET,2021-2031(%)
- FIGURE 19.COMPARATIVE SHARE ANALYSIS OF MORE THAN 98% MEXORYL SX (ECAMSULE) MARKET,2021-2031(%)
- FIGURE 20.MEXORYL SX (ECAMSULE) MARKET,BY APPLICATION,2021(%)
- FIGURE 21.COMPARATIVE SHARE ANALYSIS OF COSMETICS MEXORYL SX (ECAMSULE) MARKET,2021-2031(%)
- FIGURE 22.COMPARATIVE SHARE ANALYSIS OF PHARMACEUTICALS MEXORYL SX (ECAMSULE) MARKET,2021-2031(%)
- FIGURE 23.COMPARATIVE SHARE ANALYSIS OF OTHERS MEXORYL SX (ECAMSULE) MARKET,2021-2031(%)
- FIGURE 24.MEXORYL SX (ECAMSULE) MARKET BY REGION,2021
- FIGURE 25.U.S. MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
- FIGURE 26.CANADA MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
- FIGURE 27.MEXICO MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
- FIGURE 28.GERMANY MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
- FIGURE 29.UNITED KINGDOM MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
- FIGURE 30.FRANCE MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
- FIGURE 31.SPAIN MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
- FIGURE 32.ITALY MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
- FIGURE 33.REST OF EUROPE MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
- FIGURE 34.CHINA MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
- FIGURE 35.INDIA MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
- FIGURE 36.JAPAN MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
- FIGURE 37.SOUTH KOREA MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
- FIGURE 38.AUSTRALIA MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
- FIGURE 39.REST OF ASIA-PACIFIC MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
- FIGURE 40.BRAZIL MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
- FIGURE 41.SAUDI ARABIA MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
- FIGURE 42.SOUTH AFRICA MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
- FIGURE 43.REST OF LAMEA MEXORYL SX (ECAMSULE) MARKET,2021-2031($MILLION)
- FIGURE 44. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 45. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 46. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 47.PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 48.COMPETITIVE DASHBOARD
- FIGURE 49.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
- FIGURE 50.L'ORÉAL S.A..: NET SALES ,($MILLION)
- FIGURE 51.SKYLEAD PHARMACEUTICALS & CHEMICALS.: NET SALES ,($MILLION)
- FIGURE 52.CHEMSCENE LLC.: NET SALES ,($MILLION)
- FIGURE 53.BIOSYNTH CARBOSYNTH.: NET SALES ,($MILLION)
- FIGURE 54.NATIONAL ANALYTICAL CORPORATION.: NET SALES ,($MILLION)
- FIGURE 55.NORNA TECHNOLOGY CO..: NET SALES ,($MILLION)
- FIGURE 56.DERMA COMPANIES.: NET SALES ,($MILLION)
- FIGURE 57.MFCI CO.,LTD.: NET SALES ,($MILLION)
- FIGURE 58.MERCK KGAA.: NET SALES ,($MILLION)
- FIGURE 59.PARCHEM FINE AND SPECIALTY CHEMICALS.: NET SALES ,($MILLION)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook